The US Department of Health and Human Services (HHS) on Thursday finalized a rule that would fine pharmaceutical companies for overcharging hospitals and clinics for drugs purchased under the 340B ...
On September 26, 2024, the Centers for Medicare & Medicaid Services (CMS) released a final rule implementing changes to the Medicaid Drug Rebate Program (MDRP). While not the focus of the agency’s ...
On March 17, 2026, the U.S. Court of Appeals for the Ninth Circuit issued a decision addressing how the False Claims Act (FCA) may apply to alleged 340B Drug Pricing Program overcharges. In United ...
HHS’ Health Resources and Services Administration has finalized a rule that sets civil monetary penalties for drug manufactures that overcharge healthcare organizations that are part of the 340B Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results